CCC — Center for Covid Control — was the healthcare operating platform behind what LOM Group's brand profile describes as the largest private testing network in the United States.
LOM's healthcare portfolio included Center for Covid Control (CCC). The LOM Group brand profile describes CCC's testing footprint as the largest private testing network in the United States, built in response to the extraordinary operational demands of the COVID-19 period.
The profile attributes CCC's scale-up to a core operating principle: respond immediately and optimise in parallel. According to the document, the CCC testing-centre network was scaled across the United States in less than twelve months and was built at speed with zero leverage.
The same material positions the healthcare work as more than a single response effort. LOM describes continued work in healthcare services against an evolving regulatory and political landscape, with an emphasis on initiating new products and services as conditions change.
These figures are reproduced from LOM Group's brand profile and represent the testing-network portfolio highlight described there.
The CCC healthcare portfolio highlight is presented by LOM as evidence of its ability to mobilise teams, capital and operations quickly while continuing to refine execution in parallel.
A network expanded across the U.S. in less than twelve months, according to the LOM profile.
The reported footprint extended across more than 29 states and involved more than 3,000 staff.
The profile states that the network was scaled with zero leverage while responding to changing healthcare conditions.
